Report cover image

Asia-Pacific (APAC) Assisted Reproductive Technology (ART) Procedures Count by Segments and Forecast to 2030

Publisher GlobalData
Published Oct 31, 2023
Length 57 Pages
SKU # GBDT18334440

Description

Asia-Pacific (APAC) Assisted Reproductive Technology (ART) Procedures Count by Segments and Forecast to 2030


Summary

GlobalData’s “Asia-Pacific Assisted Reproductive Technology (ART) Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Asia-Pacific Assisted Reproductive Technology (ART) Procedures. The databook report provides procedure volumes within segments - Intrauterine Insemination (IUI) Cycles and In Vitro Fertilization (IVF) Cycles

The Asia-Pacific Assisted Reproductive Technology (ART) Procedures report provides key information and data on -
  • Procedure volume data for Assisted Reproductive Technology (ART) Procedures related to the country. Data is provided from 2015 to 2030.
Scope

Asia-Pacific Assisted Reproductive Technology (ART) Procedures is segmented as follows -
  • Intrauterine Insemination (IUI) Cycles
  • In Vitro Fertilization (IVF) Cycles
Reasons to Buy

Asia-Pacific Assisted Reproductive Technology (ART) Procedures report helps you to develop -
  • Business strategies by identifying the key segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Develop investment strategies by identifying the key segments expected to register strong growth in the near future.

Table of Contents

57 Pages
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Assisted Reproductive Technology (ART) Procedures, Segmentation
2.3 Definitions of Procedures Covered in the Report
3 Assisted Reproductive Technology (ART) Procedures, Asia-Pacific
3.1 Assisted Reproductive Technology (ART) Procedures, Asia-Pacific, 2015-2030
3.2 Assisted Reproductive Technology (ART) Procedures, Asia-Pacific, 2015-2030
4 Assisted Reproductive Technology (ART) Procedures, Australia
4.1 Assisted Reproductive Technology (ART) Procedures, Australia, 2015-2030
4.1.1 In Vitro Fertilization (IVF) Cycles, Australia, 2015-2030
5 Assisted Reproductive Technology (ART) Procedures, China
5.1 Assisted Reproductive Technology (ART) Procedures, China, 2015-2030
5.1.1 In Vitro Fertilization (IVF) Cycles, China, 2015-2030
6 Assisted Reproductive Technology (ART) Procedures, India
6.1 Assisted Reproductive Technology (ART) Procedures, India, 2015-2030
6.1.1 In Vitro Fertilization (IVF) Cycles, India, 2015-2030
7 Assisted Reproductive Technology (ART) Procedures, Japan
7.1 Assisted Reproductive Technology (ART) Procedures, Japan, 2015-2030
7.1.1 In Vitro Fertilization (IVF) Cycles, Japan, 2015-2030
8 Assisted Reproductive Technology (ART) Procedures, South Korea
8.1 Assisted Reproductive Technology (ART) Procedures, South Korea, 2015-2030
8.1.1 In Vitro Fertilization (IVF) Cycles, South Korea, 2015-2030
9 Research Methodology
9.1 Coverage
9.2 Secondary Research
9.3 Primary Research
9.4 Market Modeling and Forecasting
9.5 Company Share Analysis
9.6 Distribution Share Analysis
9.7 Benchmarking
9.8 GlobalData Consulting
10 Appendix
11 About GlobalData
12 Contact Us
List of Tables Table 1: Assisted Reproductive Technology (ART) Procedures, Asia-Pacific, 2015-2030 Table 2: Assisted Reproductive Technology (ART) Procedures, Asia-Pacific, 2015-2022 Table 3: Assisted Reproductive Technology (ART) Procedures, Asia-Pacific, 2023-2030 Table 4: Assisted Reproductive Technology (ART) Procedures, Australia, 2015-2022 Table 5: Assisted Reproductive Technology (ART) Procedures, Australia, 2023-2030 Table 6: In Vitro Fertilization (IVF) Cycles, Australia, 2015-2022 Table 7: In Vitro Fertilization (IVF) Cycles, Australia, 2023-2030 Table 8: Assisted Reproductive Technology (ART) Procedures, China, 2015-2022 Table 9: Assisted Reproductive Technology (ART) Procedures, China, 2023-2030 Table 10: In Vitro Fertilization (IVF) Cycles, China, 2015-2022 Table 11: In Vitro Fertilization (IVF) Cycles, China, 2023-2030 Table 12: Assisted Reproductive Technology (ART) Procedures, India, 2015-2022 Table 13: Assisted Reproductive Technology (ART) Procedures, India, 2023-2030 Table 14: In Vitro Fertilization (IVF) Cycles, India, 2015-2022 Table 15: In Vitro Fertilization (IVF) Cycles, India, 2023-2030 Table 16: Assisted Reproductive Technology (ART) Procedures, Japan, 2015-2022 Table 17: Assisted Reproductive Technology (ART) Procedures, Japan, 2023-2030 Table 18: In Vitro Fertilization (IVF) Cycles, Japan, 2015-2022 Table 19: In Vitro Fertilization (IVF) Cycles, Japan, 2023-2030 Table 20: Assisted Reproductive Technology (ART) Procedures, South Korea, 2015-2022 Table 21: Assisted Reproductive Technology (ART) Procedures, South Korea, 2023-2030 Table 22: In Vitro Fertilization (IVF) Cycles, South Korea, 2015-2022 Table 23: In Vitro Fertilization (IVF) Cycles, South Korea, 2023-2030
List of Figures
Figure 1: Assisted Reproductive Technology (ART) Procedures, Asia-Pacific, 2015-2030
Figure 2: Assisted Reproductive Technology (ART) Procedures, Asia-Pacific, 2015-2022
Figure 3: Assisted Reproductive Technology (ART) Procedures, Asia-Pacific, 2023-2030
Figure 4: Assisted Reproductive Technology (ART) Procedures, Australia, 2015-2022
Figure 5: Assisted Reproductive Technology (ART) Procedures, Australia, 2023-2030
Figure 6: In Vitro Fertilization (IVF) Cycles, Australia, 2015-2022
Figure 7: In Vitro Fertilization (IVF) Cycles, Australia, 2023-2030
Figure 8: Assisted Reproductive Technology (ART) Procedures, China, 2015-2022
Figure 9: Assisted Reproductive Technology (ART) Procedures, China, 2023-2030
Figure 10: In Vitro Fertilization (IVF) Cycles, China, 2015-2022
Figure 11: In Vitro Fertilization (IVF) Cycles, China, 2023-2030
Figure 12: Assisted Reproductive Technology (ART) Procedures, India, 2015-2022
Figure 13: Assisted Reproductive Technology (ART) Procedures, India, 2023-2030
Figure 14: In Vitro Fertilization (IVF) Cycles, India, 2015-2022
Figure 15: In Vitro Fertilization (IVF) Cycles, India, 2023-2030
Figure 16: Assisted Reproductive Technology (ART) Procedures, Japan, 2015-2022
Figure 17: Assisted Reproductive Technology (ART) Procedures, Japan, 2023-2030
Figure 18: In Vitro Fertilization (IVF) Cycles, Japan, 2015-2022
Figure 19: In Vitro Fertilization (IVF) Cycles, Japan, 2023-2030
Figure 20: Assisted Reproductive Technology (ART) Procedures, South Korea, 2015-2022
Figure 21: Assisted Reproductive Technology (ART) Procedures, South Korea, 2023-2030
Figure 22: In Vitro Fertilization (IVF) Cycles, South Korea, 2015-2022
Figure 23: In Vitro Fertilization (IVF) Cycles, South Korea, 2023-2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us